五菱汽車(00305.HK)完成先舊後新配售2.23億股
格隆匯 2 月 1日丨五菱汽車(00305.HK)發佈公吿,配售事項及認購事項已分別於2021年1月26日及2月1日完成。配售代理根據配售及認購協議的條款及條件成功按配售價每股配售股份2.47港元,向不少於六名承配人配售合共2.23億股配售股份。
此外,由於認購事項的所有條件均已達成,公司於2月1日按每股2.47港元向賣方配發及發行2.23億股認購股份(相當於根據配售事項成功配售的配售股份數目)。認購股份相當於經配發及發行認購股份擴大後的公司已發行股本約6.76%。認購事項所得款項淨額約為5.378億港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.